SBC Medical Group Holdings Incorporated
SBC
$3.31
$0.154.75%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -10.93% | -18.33% | -18.35% | -13.65% | -28.76% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -10.93% | -18.33% | -18.35% | -13.65% | -28.76% |
| Cost of Revenue | 0.85% | 29.41% | -2.44% | -37.24% | -44.43% |
| Gross Profit | -14.60% | -29.20% | -23.87% | -4.52% | -21.89% |
| SG&A Expenses | 11.89% | -51.17% | 22.79% | -8.33% | -60.40% |
| Depreciation & Amortization | 14.05% | 3.72% | 82.37% | -52.37% | -- |
| Other Operating Expenses | -84.32% | -53.30% | 296.38% | 145.25% | 116.65% |
| Total Operating Expenses | 8.42% | -30.01% | 11.60% | -23.79% | -35.76% |
| Operating Income | -35.03% | 14.79% | -46.67% | -1.06% | -17.56% |
| Income Before Tax | 206.42% | 41.19% | -50.01% | 15.62% | -74.29% |
| Income Tax Expenses | 977.43% | -44.77% | 30.15% | 17.84% | -105.23% |
| Earnings from Continuing Operations | 118.08% | 352.75% | -86.85% | 14.62% | -53.98% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -814.94% | -443.75% | 125.24% | 40.00% | -107.73% |
| Net Income | 117.16% | 352.70% | -86.70% | 14.63% | -54.41% |
| EBIT | -35.03% | 14.79% | -46.67% | -1.06% | -17.56% |
| EBITDA | -34.70% | 11.95% | -45.98% | -2.55% | -22.00% |
| EPS Basic | 117.61% | 319.13% | -87.92% | 4.57% | -58.24% |
| Normalized Basic EPS | -15.44% | 29.01% | -54.25% | -11.46% | -56.22% |
| EPS Diluted | 117.61% | 319.13% | -87.92% | 4.57% | -58.24% |
| Normalized Diluted EPS | -15.44% | 29.01% | -54.25% | -11.46% | -56.22% |
| Average Basic Shares Outstanding | -0.18% | 7.94% | 9.89% | 9.64% | 9.09% |
| Average Diluted Shares Outstanding | -0.18% | 7.94% | 9.89% | 9.64% | 9.09% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |